Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
25.22
+1.38 (5.79%)
At close: Jan 16, 2026, 4:00 PM EST
25.25
+0.03 (0.12%)
After-hours: Jan 16, 2026, 5:38 PM EST
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $1.46 billion as of January 16, 2026. Its market cap has increased by 104.45% in one year.
Market Cap
1.46B
Enterprise Value
1.28B
1-Year Change
104.45%
Ranking
Category
Stock Price
$25.22
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $1.46B, an increase of 816.53%. That is a compound annual growth rate of 60.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.46B | 26.29% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | 159.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |